Research

Over recent years, we have seen a large expansion in the number of available treatments for people living with relapsing-remitting multiple sclerosis (RRMS).  As well as this, we have recently seen a number...

On December 4, 2019, Brett Drummond (Co-Founder of MStranslate and Chief Science Communicator) held a Facebook Live event to explain and discuss a number of recent important developments in multiple sclerosis...

In April 2018, we published this video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod). With this therapy recently approved for the treatment of...

On a recent visit to Melbourne, Australia, Prof Amit Bar-Or (University of Pennsylvania) sat down with Prof Trevor Kilpatrick (University of Melbourne, Florey Institute of Neuroscience and Mental Health) to...

...

A newly published study from the University of Cambridge has found that fasting, as well as a common diabetes drug that mimics fasting, can improve myelin repair. In the above video, our co-founder and...

ECTRIMS 2019 has officially ended.  It is safe to say that it was a huge three days and I am exhausted!  I really hope that you have enjoyed the video summaries from Day 1 and Day 2.  With the conference...

Recently, I arrived in the United Kingdom and headed north to the city of Liverpool.  While I’m a fan of The Beatles and a passionate Liverpool Football Club supporter in the Premier League, I had other...

In our most recent Facebook Live Q&A, once again facilitated by our co-founder and chief science communicator, Brett Drummond, a special announcement was made. We were excited to share that, for the second...

Research Summary: Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis Ask people living with multiple sclerosis what their worst symptom is and they will probably...